These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29545433)

  • 21. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
    Nichani JR; de Carpentier J
    J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophilic Esophagitis Caused by Grass Pollen Sublingual Immunotherapy With Tolerance to a Subcutaneous Extract.
    Skrabski F; Pérez-Pallisé ME; Domínguez Estirado A; López Tovar C; Bermejo-Becerro A; Rodríguez Mazariego E; Zubeldia JM; Prieto García A
    J Investig Allergol Clin Immunol; 2022 Jul; 32(4):315-317. PubMed ID: 34661538
    [No Abstract]   [Full Text] [Related]  

  • 23. Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen-specific basophil response; a real-life, nonrandomized controlled study.
    Zidarn M; Košnik M; Šilar M; Bajrović N; Korošec P
    Allergy; 2015 May; 70(5):547-55. PubMed ID: 25627309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Case of pollinosis to grass pollens who presented with dyspnea successfully treated by rush immunotherapy].
    Kawada Y; Takamasu T; Inuo C; Aikawa H; Kurihara K
    Arerugi; 2007 Nov; 56(11):1403-7. PubMed ID: 18059155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is eosinophilic esophagitis an equivalent of pollen allergic asthma? Analysis of biopsies and therapy guided by component resolved diagnosis.
    Armentia A; Martín-Armentia S; Martín-Armentia B; Santos-Fernández J; Álvarez R; Madrigal B; Fernández-González D; Gayoso S; Gayoso MJ
    Allergol Immunopathol (Madr); 2018; 46(2):181-189. PubMed ID: 29338961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
    Devillier P; Wahn U; Zielen S; Heinrich J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Grazax for hay fever?
    BMJ Group
    Drug Ther Bull; 2008 Feb; 46(2):9-10. PubMed ID: 18256175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study.
    Cirla AM; Cirla PE; Parmiani S; Pecora S
    Allergol Immunopathol (Madr); 2003; 31(1):31-43. PubMed ID: 12573207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.
    Senna GE; Calderon M; Milani M
    Expert Rev Clin Immunol; 2011 Jan; 7(1):21-7. PubMed ID: 21162646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
    Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study.
    Pfaar O; Richter HG; Klimek L; Sieber J; Hadler M; Karagiannis E
    Biomed Res Int; 2015; 2015():584291. PubMed ID: 26351635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and tolerability of seasonal ultra-rush, high-dose sublingual-swallow immunotherapy in allergic rhinitis to grass and tree pollens: an observational study in 193 children and adolescents.
    Seidenberg J; Pajno GB; Bauer CP; La Grutta S; Sieber J
    J Investig Allergol Clin Immunol; 2009; 19(2):125-31. PubMed ID: 19476016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germination of pollen grains in the oesophagus of individuals with eosinophilic oesophagitis.
    Armentia A; Martín-Armentia S; Álvarez-Nogal R; Armentia BM; Gayoso MJ; Fernández-González D
    Clin Exp Allergy; 2019 Apr; 49(4):471-473. PubMed ID: 30418690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta-analysis.
    Di Bona D; Plaia A; Scafidi V; Leto-Barone MS; Di Lorenzo G
    J Allergy Clin Immunol; 2010 Sep; 126(3):558-66. PubMed ID: 20674964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study.
    Wahn U; Klimek L; Ploszczuk A; Adelt T; Sandner B; Trebas-Pietras E; Eberle P; Bufe A;
    J Allergy Clin Immunol; 2012 Oct; 130(4):886-93.e5. PubMed ID: 22939758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A national audit of pollen immunotherapy for children in the United Kingdom: patient selection and programme safety.
    Vance GH; Goldring S; Warner JO; Cox H; Sihra B; Hughes S; Gardner J; North J; Roberts G; Proudfoot CA; Clarke A; Luyt DK; Gillies D; Fox AT
    Clin Exp Allergy; 2011 Sep; 41(9):1313-23. PubMed ID: 21762222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial.
    Kleine-Tebbe J; Ribel M; Herold DA
    Allergy; 2006 Feb; 61(2):181-4. PubMed ID: 16409193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Both sublingual and supralingual routes of administration are effective in long-term allergen-specific immunotherapy.
    Panzner P; Petráš M; Sýkora T; Lesná IK; Liška M
    Allergy Asthma Proc; 2011; 32(2):142-50. PubMed ID: 21439167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.